Find XO: Bio Deeptech Innovation: Combining Infrastructure and Capital (venturesquare.net)

- SNS Lab and MYSC have signed an agreement linking an 850-pyeong shared laboratory with a 100 billion KRW impact fund. - For bio deeptech teams that spend hundreds of millions of won solely on equipment and lab space, this means a way to secure both space and funding at once, along with Proof of Concept (PoC) opportunities for expansion into Southeast Asia. - However, merely gathering under one roof does not guarantee smooth transitions from research to investment and overseas validation. - Let's watch whether tenant companies actually move on to the next stage.